G3 (Retatrutide) is a triple agonist targeting GLP-1, GIP, and glucagon receptors. Referenced in emerging metabolic and obesity research for its multi-receptor engagement profile.
Specifications: Lyophilized. Amber glass, crimp-sealed. Per vial as selected.